{
  "trial_id": "NCT00882895",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age 18 to 70 years",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Histologically proven non-Hodgkin's lymphoma",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Relapsed or refractory disease",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "ECOG performance status < or = 2",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Underwent Autologous SCT 60-120 days prior to registration",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Minimum of 2 x 10^6 CD34+ cells/kg infused",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Full hematologic recovery following Auto HCT",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Available matched related or unrelated donor",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Women of child-bearing potential and sexually active males must use an accepted and effective method of birth control",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Bone marrow comprising of < 10% lymphoma on most recent biopsy/aspiration",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Serum bilirubin < or = 2 x the institutional ULN",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Serum creatinine < or = 2 x the institutional ULN and measured or estimated creatinine clearance > 60 cc/min",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior autologous or allogeneic hematopoietic cell transplantation (other than autologous SCT 60-120 days prior to registration)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Known or suspected progressive disease following autologous SCT",
      "label": "not_met",
      "evidence": ""
    }
  ],
  "notes": "Patient has multiple myeloma with recurrent disease and systemic amyloidosis, on hemodialysis for ESRD. She was treated with various regimens including melphalan, prednisone, VAD, thalidomide, and velcade.",
  "_meta": {
    "topic_id": "17",
    "trial_id": "NCT00882895",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}